CYP3A5 genotype, but not CYP3A4*1b, CYP3A4*22, or hematocrit, predicts tacrolimus dose requirements in Brazilian renal transplant patients

Clin Pharmacol Ther. 2013 Aug;94(2):201-2. doi: 10.1038/clpt.2013.68. Epub 2013 Apr 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cytochrome P-450 CYP3A / genetics*
  • Cytochrome P-450 CYP3A / metabolism*
  • Female
  • Hematocrit*
  • Humans
  • Immunosuppressive Agents / pharmacokinetics*
  • Kidney Transplantation / immunology*
  • Male
  • Tacrolimus / pharmacokinetics*

Substances

  • Immunosuppressive Agents
  • Cytochrome P-450 CYP3A
  • Tacrolimus